| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.753 | 15.723 | 21.313 | 17.684 | 12.717 | 17.574 | 49.981 | 59.650 | 22.614 | 19.679 |
| Total Income - EUR | 3.753 | 17.223 | 21.375 | 17.698 | 12.723 | 17.599 | 49.984 | 66.942 | 22.830 | 19.680 |
| Total Expenses - EUR | 5 | 6.059 | 15.573 | 16.573 | 20.402 | 13.508 | 24.385 | 34.866 | 22.017 | 21.590 |
| Gross Profit/Loss - EUR | 3.748 | 11.164 | 5.802 | 1.125 | -7.679 | 4.091 | 25.599 | 32.076 | 813 | -1.911 |
| Net Profit/Loss - EUR | 3.629 | 10.703 | 5.015 | 595 | -8.060 | 3.563 | 24.178 | 30.291 | -117 | -2.279 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Lovaram Biotechnik Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 565 | 340 | 123 | 0 | 0 | 8.140 | 6.087 | 8.746 |
| Current Assets | 3.851 | 14.521 | 18.496 | 18.966 | 25.124 | 26.318 | 41.675 | 39.770 | 39.832 | 34.584 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 473 | 0 | 0 | 0 |
| Receivables | 3.753 | 5.973 | 6.018 | 5.920 | 5.403 | 4.635 | 8.576 | 27.215 | 27.774 | 31.998 |
| Cash | 97 | 8.548 | 12.478 | 13.047 | 19.721 | 21.683 | 32.626 | 12.554 | 12.058 | 2.586 |
| Shareholders Funds | 3.622 | 14.288 | 19.062 | 19.307 | 8.765 | 12.162 | 36.071 | 36.057 | 35.781 | 33.301 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 228 | 233 | 0 | 0 | 16.482 | 14.156 | 5.604 | 14.747 | 13.038 | 12.912 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Lovaram Biotechnik Srl